Volume 21 - Issue 12 - December, 2009
Preprocedural Inflammation Does Not Affect Neointimal Hyperplasia following Everolimus-Eluting Stent Implantation
- Fri, 12/4/09 - 12:39pm
- 0 Comments
- 6433 reads
ABSTRACT: Background. Preprocedual C-reactive protein (CRP) has been reported to correlate with in-stent restenosis following bare-metal stent implantation. The aim of this study was to investigate the impact of preprocedural inflammation on neointimal hyperplasia assessed by intravascular ultrasound (IVUS) following everolimus-eluting stent (EES) implantation. Methods. We identified 134 patients meeting the following criteria: 1) patients treated with EES; 2) those with stable or unstable angina; and 3) patients available for high-sensitivity (hs)-CRP before the procedure and volumetric IVUS
Management of Guidewire-Induced Coronary Artery Perforations through Transradial Route-A Simple Approach
- Mon, 12/7/09 - 11:16am
- 0 Comments
- 4358 reads
From the †Total Cardiovascular Solutions Private Limited, and Sheth V.S.General Hospital, Ahmedabad, India.
The authors report no conflicts of interest regarding the content herein.
Manuscript submitted June 19, 2009, provisional acceptance given July 20, 2009, final version accepted August 3, 2009.
Address for correspondence: Tejas Patel, MD, FACC, FSCAI, Professor and Head, Department of Cardiology, Sheth V.S.General Hospital, Ahmedabad-380 006, India. E-mail: tejaspatel@tcvsgroup.org
_______________________________________________
Validation of a Risk Score for Target Vessel Revascularization after Coronary Stent Implantation
- Fri, 12/4/09 - 12:45pm
- 0 Comments
- 4189 reads
ABSTRACT: Objective. Our aim was to validate a risk score for new target vessel revascularization (TVR) after bare-metal stent (BMS) implantation. Methods. The risk score was developed in a cohort of patients previously treated with BMS at our institution. This risk score ranges from 0 to 5 points, according to the presence of diabetes mellitus (1 point), reference vessel diameter (> 3.5 mm = 0 points; 3–3.5 mm = 1; < 3 mm = 2) and lesion length (≤ 10 mm = 0 points; 10–20 mm = 1; > 20 mm = 2). Patients included in the validation cohort were treated between January and December 2005. Pati
Very Late Thrombosis of a Sirolimus-Eluting Stent after 57 Months
- Mon, 12/7/09 - 11:19am
- 0 Comments
- 2086 reads
From the *University of Miami Miller School of Medicine, and Charles E. Schmidt College of Science, Florida Atlantic University, Boca Raton, Florida, and §Nova Southeastern College of Medicine, Ft. Lauderdale, Florida.
The authors report no conflicts of interest regarding the content herein.
Manuscript submitted May 29, 2009, provisional acceptance given June 24, 2009, final version accepted July 7, 2009.
Address for correspondence: Anil Paturi, MD, Internal Medicine Residency Program, JFK Medical Center, 4 South, 5301 S. Congress, Atlantis, FL 33462. E-mail: apaturi@me
A Novel “In-Situ Tulip-Bud Deployment” Method for Transcatheter Closure of Secundum Atrial Septal Defect
- Fri, 12/4/09 - 12:49pm
- 0 Comments
- 5195 reads
ABSTRACT: Objective. We devised a new technique for interventional closure of atrial septal defect (ASD) using the Amplatzer Septal Occluder (ASO), and validated this by comparing it with a cohort using the conventional method. Background. Transcatheter closure of ASD is a widely accepted modality of treatment. Although the outcome is good, there are occasional technical difficulties encountered. Method. In this three-step technique, the device is protruded to form a “tulip bud.” This “tulip bud” is then aligned adjacent to and along the plane of the ASD. The second step involves withd
Primary Antiphospholipid Syndrome with Recurrent Coronary Thrombosis, Acute Pulmonary Thromboembolism and Intracerebral Hematoma
- Mon, 12/7/09 - 11:22am
- 0 Comments
- 6485 reads
From the Department of Cardiology, Royal Hospital, Muscat, Oman.
The authors report no conflicts of interest regarding the content herein.
Manuscript submitted May 21, 2009, provisional acceptance given June 8, 2009, final version accepted June 24, 2009.
Address for correspondence: Dr. Panduranga Prashanth, Department of Cardiology, Royal Hospital, Post Box 1331, Muscat-111, Oman. E-mail: prashanthp_69@yahoo.co.in
_______________________________________________
ABSTRACT: We present a young patient with myocardial infarction who had rec
Predictors of Distal Embolization in Peripheral Percutaneous Interventions: A Report from a Large Peripheral Vascular Registry
- Fri, 12/4/09 - 2:45pm
- 0 Comments
- 4907 reads
ABSTRACT: Background. Distal embolization (DE) commonly occurs during peripheral percutaneous interventions (PPI) of the lower-extremity arterial vessels. In this study we evaluate the predictors of DE in a large cohort of patients undergoing PPI at our center. Methods. Patients who experienced clinically significant DE (requiring further mechanical or pharmacologic therapy as per operator judgment) were extracted from a peripheral vascular registry that prospectively tracks demographics, clinical, procedural and outcome variables on patients undergoing PPI at our medical center and compared t
Atheroemboli during Peripheral Arterial Interventions
- Fri, 12/4/09 - 2:53pm
- 0 Comments
- 3524 reads
Atheroemboli during percutaneous peripheral arterial interventions (PAI) complicate about 1–2% of procedures, with serious adverse outcomes, although their true incidence is estimated to be much greater.1 In the era of increasing number and complexity of percutaneous peripheral arterial revascularization procedures, it is important to provide operators with guidance regarding the predictors of this rare though serious complication. The rarity and often unpredictability of atheroembolic complications during PAI makes this article by Shammas et al extremely relevant to today’s endovascular s
- « Previous
- | Page 1 of 3 |
- Next »
